1. Miltefosine: a novel internal standard approach to lysophospholipid quantitation using LC-MS/MS
- Author
-
A. Ruth Godfrey, Mairead Davies, Rachel Townsend, and Lewis Jones
- Subjects
0301 basic medicine ,Accuracy and precision ,Bioanalysis ,Internationality ,Phosphorylcholine ,Analytical chemistry ,Sensitivity and Specificity ,01 natural sciences ,Biochemistry ,Mass Spectrometry ,Analytical Chemistry ,Matrix (chemical analysis) ,Plasma ,03 medical and health sciences ,Lc ms ms ,medicine ,Humans ,Solid phase extraction ,Liquid chromatography-mass spectrometry ,Detection limit ,Miltefosine ,Chromatography ,Lysophosphatidylcholine quantitation ,Chemistry ,010401 analytical chemistry ,Extraction (chemistry) ,Reproducibility of Results ,Reference Standards ,0104 chemical sciences ,030104 developmental biology ,lipids (amino acids, peptides, and proteins) ,Lysophospholipids ,Algorithms ,Blood Chemical Analysis ,Chromatography, Liquid ,Research Paper ,medicine.drug - Abstract
Understanding and determining levels of lysophospholipids (LPLs) is of increasing interest to the bioanalytical community as they may be targeted for preparative removal as a matrix interference or as a lead substance as a biomarker of disease. Studies monitoring levels of LPLs have used a range of approaches for quantitation whereby those using an internal standard have used either deuterated analogues of the target LPL or alternative LPLs containing an odd number of carbon atoms within its chain, which can be expensive and difficult to distinguish with other LPLs, respectively. A structural analogue, miltefosine, was investigated as a novel internal standard to quantify a selection of lysophosphatidylcholines (LPCs) of clinical interest. A reverse phase C18 LC-MS/MS method was characterised for 16:0-LPC, 18:1-LPC and 18:0-LPC, showing good sensitivity and linearity for all compounds, with limit of detection (LOD) values
- Published
- 2017